Azathioprine Metabolism: Pharmacokinetics of 6‐Mercaptopurine, 6‐Thiouric Acid and 6‐Thioguanine Nucleotides in Renal Transplant Patients

The Journal of Clinical Pharmacology

Volumn 30, Issue 4, 1990, Pages 358-363

  Chan, Gary L C ^a   Erdmann, Gary R ^a   Gruber, Scott A ^a   Matas, Arthur J ^a   Canafax, Daniel M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 THIOURIC ACID; AZATHIOPRINE; AZATHIOPRINE DERIVATIVE; CYCLOSPORIN; MERCAPTOPURINE; PREDNISONE; SULFAMETHOXAZOLE; TIOGUANINE; TRIMETHOPRIM;

ADULT; ARTICLE; BACTERIAL INFECTION; BONE MARROW TOXICITY; CLINICAL ARTICLE; FEMALE; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; MALE; NEPHROTOXICITY; PH;

6-MERCAPTOPURINE; ADMINISTRATION, ORAL; ADULT; AZATHIOPRINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DATA COLLECTION; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGE; SUPPORT, U.S. GOV'T, P.H.S.; THIOGUANINE; TIME FACTORS; URIC ACID;

EID: 0025034447     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1990.tb03606.x     Document Type: Article

References (16)

1. New immunosuppressive drug combinations for mismatched related and cadaveric renal transplantation
2. HLA‐identical sibling renal transplants: No rejections with a cyclosporineazathioprine‐prednisone protocol
3. Leukopenia and azathioprine management in renal homotransplantation
4. Serum azathioprine and 6‐mercaptopurine levels and immunosuppressive activity after azathioprine in uremic patients
5. Azathioprine dosage schedule and rejection episodes in renal transplant recipients
6. Assay of 6‐thioguanine nucleotide, a major metabolite of azathioprine, 6‐mercaptopurine and 6‐thioguanine, in human red blood cells
7. HPLC determination of 6‐thiouric acid and 6‐mercaptopurine in organ transplant patient serum
8. A reverse‐phase HPLC approach in determining total red blood cell concentrations of 6‐thioguanine, 6‐mercaptopurine, methylthioguanine, and methylmercaptopurine in a patient receiving thiopurine therapy
9. Thiopurines
10. A rapid and sensitive high‐performance liquid chromatographic assay for 6‐mercaptopurine metabolites in red blood cells
11. Distinction between inhibition of purine nucleotide synthesis and the delayed cytotoxic reaction of 6‐mercaptopurine
12. Azathioprine metabolism in kidney transplant recipients
13. Severe megaloblastic anaemia associated with abnormal azathioprine metabolism
14. Childhood leukaemia: a relationship between intracellular 6‐mercaptopurine metabolites and neutropenia
15. Thiopurine pharmacogenetics in leukemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6‐thioguanine nucleotide concentrations
16. Pharmacokinetics of azathioprine metabolites, 6 ‐thiouric acid and 6‐mercaptopurine, in renal allograft recipients